10.1164/rccm.200508-1281OC
Traditional first-line agents are expensive and may have disruptive side effects
L-Carnitine homeostasis reflects the balance among intestinal absorption, biosynthesis in several tissues, including the liver, kidney, and brain, renal reabsorption, and muscular storage ( Our previous study demonstrated that a 14-day daily administration of lenvatinib to rats reduced OCTN2 protein levels in the skeletal muscle and intestine, but not in the kidney, and consequently decreased L-carnitine content in the skeletal muscle ( in vitro
At the same time, it blocks lipogenesis, preventing new fat storage
What the Research Currently Tells Us The honest starting point is this: the research on GLP-1 medications and eating disorders is still limited, and what exists is mixed